Business Wire

Employees Want the Best of Both Worlds: New Survey From Condeco Reveals Critical Facets of Hybrid Work That Business Leaders Need to Address

Share

Condeco, a global leader in workspace scheduling software, is today announcing new research that reveals the importance of fostering a workplace that understands and respects employee needs, with hybrid work opportunities at its core. Its findings support the understanding that hybrid capabilities lead to greater employee advocacy and happiness at work and show that when it comes to recommending their company, hybrid workers can be the biggest advocates.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220412005267/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

Allowing for a better work-life balance was identified as one of the biggest benefits of hybrid working through Condeco’s new research, which shows a direct relationship between employee satisfaction and improved mental and emotional well-being. Significantly, more than a third of workers surveyed reported that a hybrid work model has positively impacted their mental and physical health.

“Everyone wants something different out of work, but we can clearly see that almost no one wants to be back in the office full-time,” said Paul Statham, Condeco’s CEO & Founder. “We all know by now that hybrid models are key to ensuring a healthy work-life balance, but how each employer acts on that realization will determine their employees’ fulfillment with their company. No one is suggesting that the office is obsolete, on the contrary, it remains a vital place for employees to collaborate and engage. Business leaders looking to provide the best of both worlds for their employees must find a way to transform their offices from a place employees have to go to a place they want to go.”

“The need to have the right digital tools in place has emerged as one of the most important things to get right for hybrid working,” continued Lynda Lowe, CMO at Condeco. “But different generations have different definitions of what the ‘right tools’ are. This research clearly shows the biggest barriers to hybrid working and the fact that many employees still don’t feel that their company is using the right tools for hybrid working.”

Condeco polled 1,500 of today’s workers to get a pulse on the attitudes towards hybrid work and how these feelings are impacting businesses’ acclimation to the future of the working world. Key findings include:

Hybrid Workers Are Happy Workers – And in Turn, They’re Your Most Loyal Employees

  • 62% of respondents said they feel satisfied with their current hybrid work schedule – and fostering a work culture that brings happiness helps employers attract and retain top talent.
  • Hybrid workers are employers’ biggest advocates, with 63% saying they would recommend their company as an ideal work destination.
  • Nearly half of those back in their offices full-time would like to be more hybrid, which employers struggling with the ‘Great Resignation’ appear not to be considering.

Hybrid Work Has Had a Positive Impact on Mental Health, But There Is Still Room for Improvement

  • 34% of respondents feel that hybrid working has had a positive impact on their mental and physical health, with only 11% feeling that it has had a negative effect.
  • 69% of hybrid workers agreed that their employer takes into consideration the emotional and mental wellbeing of employees.
  • The number one benefit of hybrid working was a better work-life balance, with the lack of a social environment offered by work being the biggest barrier to remote working.

Tech Is the Backbone of Hybrid Work – Yet Only Half of Today’s Employees Have the Right Tools

  • Businesses have realized the opportunity of hybrid working – 78% of managers believe their business has been streamlined as a result and 80% trust their employees to get their work done.
  • Having the right digital tools was identified as the top need to ensuring hybrid working, but only 51% of employees agree that their company is using the right tools to support flexible work and only 50% of respondents feel their company is open to feedback about their digital tool stack.
  • Companies are grappling with how best to bring employees back to the office on a flexible basis. To ensure collaboration and high productivity, employers must consider their workplace tech as the backbone to their strategy.

As part of Condeco’s broader marketing campaign that addresses today’s cultural shift in business, Condeco is today releasing a new film short that shines light on the generational divide that has emerged out of the pandemic, and light-heartedly cements the importance of having an employer that understands and embraces employee needs. You can see the full broadcast here.

To download Condeco’s full survey, complete with additional statistics and methodology, please visit: https://www.condecosoftware.com/modern-workplace/research/attitudes-to-hybrid-working-report-2022/.

About Condeco

Condeco is the global leader in enterprise level workspace solutions. Our software is designed to equip everyone with the tools they need for a seamless end to end experience in today’s office. By giving people control over flexible work, we deliver the certainty people need, enable the collaboration teams crave, and facilitate the insights on capacity that employers demand. From visitor management to workspace booking to office optimization, we are trusted by over 2000 of the world’s largest companies to realize their future at work.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Sydney Huffman
sydney.huffman@fleishman.com
(203) 247-9784

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 14:30:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 14:00:00 CEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

HiddenA line styled icon from Orion Icon Library.Eye